Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07082244 · ClinicalTrials.gov registry record · NA
Implant Phenotype Modification Via GBR and ADM
A NA study of Horizontal Ridge Deficiency, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07082244 is a NA study of Horizontal Ridge Deficiency that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07082244, a NA study of Horizontal Ridge Deficiency, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Single implant sites with bone loss can often be managed by bone grafting alone. The purpose of this study is to determine whether putting a soft tissue graft substitute over the bone graft will provide an increased benefit for improving the health, appearance, and stability of the bone and gums surrounding the implant.
Conditions Studied
Interventions
- PROCEDURE Dental implant placement
- PROCEDURE Guided bone regeneration with collagen membrane
- PROCEDURE Guided bone regeneration with acellular dermal matrix.
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07082244
The ClinicalTrials.gov registry entry for NCT07082244 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Horizontal Ridge Deficiency appearing as the primary indexed condition, and to 3 interventions - of which Dental implant placement is the first listed.
NCT07082244 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT07082244 about?
NCT07082244 is a clinical study titled "Implant Phenotype Modification Via GBR and ADM". Single implant sites with bone loss can often be managed by bone grafting alone. The purpose of this study is to determine whether putting a soft tissue graft substitute over the bone graft will provide an increased benefit for improving the health, appearance, and stability of the bone and gums sur...
What is the current status of trial NCT07082244?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-01. Estimated completion is 2026-09-01.
What conditions does trial NCT07082244 study?
This clinical trial studies the following conditions: Horizontal Ridge Deficiency.
What interventions are being tested in trial NCT07082244?
The interventions under investigation include: Dental implant placement (PROCEDURE), Guided bone regeneration with collagen membrane (PROCEDURE), Guided bone regeneration with acellular dermal matrix. (PROCEDURE).
Who is sponsoring clinical trial NCT07082244?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07082244 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.